Home › Funds › PANAGORA ASSET MANAGEMENT INC › REGN
PANAGORA ASSET MANAGEMENT INC position in REGN
REGENERON PHARMACEUTICALS · Health Care
PANAGORA ASSET MANAGEMENT INC reported holding 239,649 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$181.7M, representing 0.55% of its reported portfolio and ranking #28 among its reported holdings. PANAGORA ASSET MANAGEMENT INC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How PANAGORA ASSET MANAGEMENT INC's REGN position evolved
PANAGORA ASSET MANAGEMENT INC first disclosed a stake in REGN in Q3 2023 at 158,444 shares (US$130.4M). The position peaked in Q3 2026 at 239,649 shares, worth US$181.7M. Across 13 filings, PANAGORA ASSET MANAGEMENT INC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 239,649 shares valued at US$181.7M — an increase of 64,358 shares quarter over quarter.. Notable position changes include a 98% trim in Q2 2025 (shares rose 8% over the following quarter), a 3463% increase in Q3 2025 (shares rose 36% over the following quarter), a 121% increase in Q1 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 158.44K | $130.39M | New |
| Q4 2023 | 154.96K | $136.10M | Reduce |
| Q1 2024 | 167.96K | $161.66M | Add |
| Q2 2024 | 170.76K | $179.47M | Add |
| Q3 2024 | 152.16K | $159.96M | Reduce |
| Q4 2024 | 103.28K | $73.57M | Reduce |
| Q1 2025 | 102.95K | $65.29M | Hold |
| Q2 2025 | 2.18K | $1.14M | Reduce |
| Q3 2025 | 77.67K | $43.67M | Add |
| Q4 2025 | 47.69K | $36.81M | Reduce |
| Q1 2026 | 105.22K | $81.30M | Add |
| Q2 2026 | 175.29K | $109.30M | Add |
| Q3 2026 | 239.65K | $181.72M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on PANAGORA ASSET MANAGEMENT INC
FAQ
How long has PANAGORA ASSET MANAGEMENT INC held REGN?
PANAGORA ASSET MANAGEMENT INC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is PANAGORA ASSET MANAGEMENT INC's current position in REGN?
As of Q3 2026, PANAGORA ASSET MANAGEMENT INC holds 239.65K shares of REGN (REGENERON PHARMACEUTICALS), valued at $181.72M, representing 0.55% of its reported portfolio and ranking #28.
Has PANAGORA ASSET MANAGEMENT INC been buying or selling REGN?
In the latest 13F filing (Q3 2026), PANAGORA ASSET MANAGEMENT INC increased its position in REGN. The position peaked in Q3 2026 at 239.65K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.